Medical
About Us
Investor Relations
In the clinical diagnostics industry, companies face a persistently challenging business environment due to ongoing medical cost control measures and rising raw material and transportation costs driven by geopolitical factors. To overcome this environment, we will pursue initiatives to become more cost-competitive and expand overseas with greater aggression and strategic intent. In Japan, the promotion of community-based integrated care systems has already begun in response to the diversifying medical and nursing care needs in an aging society. Overseas, continued growth is expected due to the need for efficiency in controlling medical costs and the expansion of preventive medicine in developed countries, as well as the development of medical infrastructure in conjunction with population growth and economic development in emerging countries.
Based on our management philosophy of “Protect the health of the public through health care services,” the Eiken Group will contribute to protecting the health of even more people through global expansion and aim for further growth.
With the aim of flexibly responding to changes in the business environment, the Group has adopted the perspective of sustainability management and has set EIKEN ROAD MAP 2030 as a goal for 2030. In fiscal 2025, we adopted the second Medium-Term Management Plan for EIKEN ROAD MAP 2030. In this plan, we will respond to the accelerating paradigm shift in healthcare and the rapidly changing external environment, and will also strengthen our management base. As a foundation for these initiatives, we have further strengthened our three basic policies of “Business strategies,” “Finance Capital strategies,” and “Governance,” by looking back on our previous Medium-Term Management Plan. As a result, management and employees under the new structure will work together to create innovation by continuing to pursue challenges with a sense of speed and a positive mindset, thereby aiming for sustainable growth and steady improvement in profitability.
We look forward to continued support and enthusiasm from all of our shareholders.
President & CEO
Yuji Segawa
Management
policy
Stock
Information